AstraZeneca (AZN) Q2 2022 Earnings Call Transcript

Prepared Remarks

Questions and Answers

Call Participants

Prepared Remarks:

Operator

Well good morning to those from the UK and US Good afternoon to those in Central Europe. And good evening to those listening in Asia. Welcome ladies and gentlemen, to AstraZeneca is half year 2022 results conference call and webcast for investors and analysts. Before I hand over to AstraZeneca I'd like to read the safe harbor statement. The company intends to utilize the safe harbor provisions of the United States private securities litigation Reform Act of 1995. participants on this call may make forward looking statements with respect to the operations and financial performance of AstraZeneca. Although we believe our expectations are based on reasonable assumptions, by their very nature, forward looking statements involve risks and uncertainties, and may be influenced by factors that could cause actual results to differ materially from those expressed or implied by these forward looking statements. Any forward looking statements made on this call reflect the knowledge and information available at the time of this call. The company undertakes no obligation to update forward looking statements.

Please also carefully review the forward looking statements disclaimer in the slide deck that accompanies this conference call and webcast will be an opportunity to ask questions after today's presentations are joining on the telephone please press star one one to indicate your wish to ask your question at any time during the call. And for those on the webcast. You will find an on screen text box in which to type your question. And with that, I will now hand you over to AstraZeneca

Andy Barnett - head of IR

Thank you, operator and welcome everyone. I'm Andy Barnett, head of Investor Relations at AstraZeneca and I'm pleased to welcome you to AstraZeneca is first half 2022 conference call. All materials presented today are available on our website. Slide two has our usual Safe Harbor statement. We will be making comments on our performance using constant exchange rates or CR core financial numbers and other non GAAP measures. And non GAAP to GAAP reconciliation is contained within the results announcement. numbers used are in millions of US dollars and for the first half unless otherwise stated. Please advance the slide three. This slide shows our agenda for today's call and in a moment I'll hand over to our CEO Pascal Surya to begin following our prepared remarks we will open the line for questions we ask that you limit yourself and limit the number of questions that you have to give everyone a fair opportunity to participate in the q&a during the allotted time. As a as a reminder for those on the phone, please join the queue by for questions by pressing star one one. With that, please advance to side four and I'll hand over to Pascal.